black box warning semaglutide Ozempic causes thyroid cancer." You've probably seen the headlines. But here's what many posts leave out: the FDA is real—but it's often oversimplified. Ozempic (semaglutide) carries a boxed warning for thyroid FDA Adds New Warning for

Effects of onceweekly exenatide on cardiovascular outcomes in type 2 diabetes

When will it be available

tirzepatide pulls two

Glucagon-like peptide-1 (GLP-1) is a hormone your body naturally produces to regulate blood sugar levels, appetite, and digestion

The efficacy of saxagliptin as add-on therapy with metformin was evaluated in 743 patients with an A1C between 7% and 10% for a 24-week period, compared to metformin alone

Expert consensus suggests considering pharmacotherapy when there is: Significant weight regain from nadir weight BMI 27 kg/m with obesity-related comorbidities or BMI 30 kg/m Absence of anatomical complications requiring surgical revision Adequate adherence to nutritional and behavioral recommendations Patient willingness to engage in long-term pharmacotherapy The American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) guidelines emphasize that pharmacologic therapy should complement, not replace, lifestyle interventions and ongoing bariatric surgical follow-up